−28.16 MEUR
19.19 M
About VIVORYON THERAPEUTICS N.V.
Sector
Industry
CEO
Frank T. Weber
Website
Headquarters
Halle
Employees (FY)
17
Founded
2001
ISIN
NL00150002Q7
FIGI
BBG0079ZD8K3
Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VVY is 0.45 EUR — it has increased by 1.07% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange VIVORYON THERAPEUTICS N.V. stocks are traded under the ticker VVY.
VIVORYON THERAPEUTICS N.V. is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for VIVORYON THERAPEUTICS N.V. has a max estimate of 64.00 EUR and a min estimate of 0.70 EUR.
Yes, you can track VIVORYON THERAPEUTICS N.V. financials in yearly and quarterly reports right on TradingView.
VVY stock has fallen by 14.29% compared to the previous week, the month change is a 22.97% fall, over the last year VIVORYON THERAPEUTICS N.V. has showed a 96.93% decrease.
Like other stocks, VVY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIVORYON THERAPEUTICS N.V. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 17.00 employees. See our rating of the largest employees — is VIVORYON THERAPEUTICS N.V. on this list?